Skip to main content
. 2018 May 8;9(35):23890–23899. doi: 10.18632/oncotarget.25156

Table 1. Response assessment (n = 9).

Dose of F50067 (mg/kg) Single agent Overall F50067 Len-Dex Overall
0.03 0.1 0.3 1 0.03 0.1
N total of patients 1 4 3 2 10 1 3 4
N response assessed* 0 2 3 1 6 1 2 3
Partial response (PR) - 0 0 0 0 1 1 2 (66.7%)
Stable disease (SD) - 0 1 1 2 (33.3%) 0 0 0
ORR (≥PR) - 0 0 0 0 1 1 2 (66.7%)
CBR (≥MR) - 0 0 0 0 1 1 2 (66.7%)
Objective response (≥SD) - 0 1 1 2 (33.3%) 1 1 2 (66.7%)

*Patients not evaluable for response: no response at cycle 1, not evaluable at cycle 1 or not eligible